Table 2.
Variables | Median survival (month) | p value |
---|---|---|
Sex | 0.824 | |
Male | 44.0 | |
Female | 41.0 | |
Age (years) | 0.482 | |
≥ 65 | 41.0 | |
< 65 | 42.0 | |
Grade | < 0.001 | |
Well or moderately differentiated | 61.0 | |
Poorly differentiated | 36.0 | |
Location | 0.405 | |
Lower | 40.5 | |
Middle | 45.0 | |
Upper | 50.0 | |
T stage | < 0.001 | |
T1 | 64.0 | |
T2 | 59.0 | |
T3 | 41.5 | |
T4 | 25.0 | |
N stage | < 0.001 | |
N0 | 60.0 | |
N1 | 47.0 | |
N2 | 31.0 | |
N3 | 18.5 | |
TNM stage | < 0.001 | |
I | 62.0 | |
II | 47.0 | |
III | 26.0 | |
LN | 0.895 | |
< 15 | 44.0 | |
≥ 15 | 41.5 | |
LNR | < 0.001 | |
0 | 60.0 | |
0–0.13 | 47.0 | |
0.13–0.4 | 35.5 | |
> 0.4 | 17.0 |
The depth of primary tumor invasion (T stage), classification of regional metastasis lymph nodes (N stage) and TNM stage were based on the 7th edition TNM staging system; LN: number of lymph nodes examined; LNR: ratio between the positive lymph nodes and the total number of lymph nodes examined